ANOVA BRCA specific result package

Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 12:18:58 iorio@ebi.ac.uk

Drug Domain: GDSC1000_paper_set, Analysis Domain: BRCA specific


Individual drug analysis: 1036


Drug details and screening numbers

Drug Name: PLX4720
Drug ID: 1036
Synonyms: Vemurafenib (derivative)
Brand name: Zelboraf (derivative)
Target: BRAF

Number of cell lines screened: 848
Screening concentration range(s): 0.0390625 to 10 uM


Statistically significant associations identified = 0


All-tests volcano plot